Dr Mahnaz Ramezanpour
Grant-Funded Researcher (A)
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Dr Mahnaz Ramezanpour is a biomedical researcher that completed her PhD in medical biotechnology in 2015 at Flinders University, Australia and authored > 42 peer-reviewed articles and 1 book chapter. Her research program largely focuses on evaluating causes of chronic rhinosinusitis (CRS), identifying new diagnostic markers and treatment strategies to the benefit of CRS patients. She collaborates widely in multidisciplinary teams of scientists, clinicians and industry partners to ensure a real-world impact of her work. She collaborated with two large biotech companies, investigating the effect of several of their commercial products on the mucosal barrier function. As lead investigator, her research has led to the development of new soon to be released medical treatments for CRS.Recently, she is using the state-of-the-art stem cell and organoid technologies for establishing airway organoids. The stem cell based organoid technology allows the culturing and expansion of a patient’s own cells in vitro in order to test and select the most effective and least toxic drug combination. She has established and characterized the nasal organoids derived from CRS patients. She is using cells, macrophages, and clinical bacteria isolates from CRS patients to evaluate and compare the effective capacity and immune response pathways of infection in the nasal organoids. Her research focus is on developing effective treatments against CRS patients and translating them from the lab to real-life applications.Available projects for HDR, Honours and 3rd Year students in 2022 include:1) Investigating new therapeutic targets to personalise treatment for CRS patients with recurrent disease.2) The use of nasal organoids as a valid alternative model for lung organoids.
Investigating new therapeutic targets to personalise treatment for CRS patients with recurrent disease.
The use of nasal organoids as a valid alternative model for lung organoids.
| Language | Competency |
|---|---|
| Persian | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2011 - 2015 | Flinders University | Australia | PhD |
| University of Adelaide, Adelaide | Australia | Postdoctoral fellow |
| Year | Citation |
|---|---|
| 2025 | Paramasivan, S., Bassiouni, A., Bokulich, N. A., Ramezanpour, M., Cooksley, C., Caporasso, J. G., . . . Vreugde, S. (2025). Tertiary Lymphoid Organs Are Associated With Bacterial Dysbiosis in Chronic Rhinosinusitis. International Forum of Allergy and Rhinology, 15(8), 869-872. |
| 2025 | Hall, J., Psaltis, A., Vreugde, S., Feizi, S., Chuah, Y., Alsharifi, M., & Ramezanpour, M. (2025). Effects of influenza A infection on liberation of bacteria from biofilms and inflammatory response in an in vitro model of chronic rhinosinusitis.. Microbiology (Reading), 171(8), 9 pages. |
| 2025 | Nepal, R., Houtak, G., Bouras, G., Feizi, S., Shaghayegh, G., Shearwin, K., . . . Vreugde, S. (2025). A φSa3int (NM3) Prophage Domestication in Staphylococcus aureus Leads to Increased Virulence Through Human Immune Evasion.. MedComm, 6(8), e70313. Scopus1 WoS1 Europe PMC1 |
| 2025 | Le, H. -P., Hassan, K., Alsenaide, M., Purasinhala, K., Tran, A. T. T., Ramezanpour, M., . . . Losic, D. (2025). Electroconductive Antibacterial Bioinks Enable Electrical Stimulation Enhancement of Proliferation and Elongation of Human Skin Fibroblasts. ACS Biomaterials Science and Engineering, 11(9), 5661-5679. |
| 2025 | MMed, X. S., Ramezanpour, M., Hall, J., Barry, E., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2025). Patient-Specific Coculture of S. aureus and P. aeruginosa Enhances Epithelial Barrier Disruption and Virulence in CRS.. Int Forum Allergy Rhinol, 12 pages. |
| 2024 | Shaghayegh, G., Cooksley, C., Bouras, G., Panchatcharam, B. S., Feizi, S., Javadian, S., . . . Vreugde, S. (2024). S. aureus biofilm properties correlate with immune B cell subset frequencies and severity of chronic rhinosinusitis. Clinical Immunology, 263, 110221-1-110221-16. Scopus3 WoS3 Europe PMC2 |
| 2024 | Le, H. -P., Hassan, K., Ramezanpour, M., Campbell, J. A., Tung, T. T., Vreugde, S., & Losic, D. (2024). Development of novel iron(III) crosslinked bioinks comprising carboxymethyl cellulose, xanthan gum, and hyaluronic acid for soft tissue engineering applications. Journal of Materials Chemistry B, 12(27), 6627-6642. Scopus10 WoS11 Europe PMC7 |
| 2024 | Tuli, J. F., Ramezanpour, M., Cooksley, C., Bouras, G. S., Ogi, K., Feizi, S., . . . Vreugde, S. (2024). Increased antibiotic resistance of Pseudomonas aeruginosa isolates from chronic rhinosinusitis patients grown in anaerobic conditions. Laryngoscope Investigative Otolaryngology, 9(3), e1244-1-e1244-9. Scopus2 WoS3 Europe PMC4 |
| 2024 | Candy, N. G., Ramezanpour, M., Bouras, G., Chegeni, N., Chataway, T., Ormsby, R. J., . . . Psaltis, A. J. (2024). Differential proteomic expression in non-functional pituitary neuroendocrine tumours and pituitary glands. Rhinology, 62(6), 750-758. Scopus1 WoS1 Europe PMC2 |
| 2024 | Ramezanpour, M., Feizi, S., Arachchige, H. D. P., Bouras, G., Cooksley, C., Shaghayegh, G., . . . Vreugde, S. (2024). Evaluation of mucosal barrier disruption due to Staphylococcus lugdunensis and Staphylococcus epidermidis exoproteins in patients with chronic rhinosinusitis. International Forum of Allergy and Rhinology, 15(3), 267-277. Scopus1 WoS1 |
| 2024 | Feizi, S., Awad, M., Ramezanpour, M., Cooksley, C., Murphy, W., Prestidge, C. A., . . . Vreugde, S. (2024). Promoting the Efficacy of Deferiprone-Gallium-Protoporphyrin (IX) against <i>Mycobacterium abscessus</i> Intracellular Infection with Lipid Liquid Crystalline Nanoparticles.. ACS applied materials & interfaces, 16(51), 70274-70283. Scopus1 WoS1 Europe PMC1 |
| 2023 | Feizi, S., Cooksley, C. M., Ramezanpour, M., Nepal, R., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2023). Colloidal silver against macrophage infections and biofilms of atypical mycobacteria.. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 36(4), 913-925. Scopus11 WoS10 Europe PMC4 |
| 2023 | Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages. Scopus3 WoS3 Europe PMC3 |
| 2023 | Cherian, L. M., Liu, S., Hon, K., Ramezanpour, M., Hu, H., Javadiyan, S., . . . Vreugde, S. (2023). Hydrocortisone metabolism by Staphylococcus: effects on anti-inflammatory and antimicrobial action.. International forum of allergy & rhinology, 14(3), 711-715. Scopus1 Europe PMC1 |
| 2022 | Menberu, M. A., Cooksley, C., Ramezanpour, M., Bouras, G., Wormald, P. -J., Psaltis, A. J., & Vreugde, S. (2022). In vitro and in vivo evaluation of probiotic properties of Corynebacterium accolens isolated from the human nasal cavity. Microbiological Research, 255, 10 pages. Scopus16 WoS15 Europe PMC13 |
| 2022 | Javadiyan, S., Germein, K. C., Cooksley, C. M., Ramezanpour, M., Singh, N., Wormald, P. -J., . . . Psaltis, A. J. (2022). In Vitro safety and anti-bacterial efficacy assessment of Acriflavine.. Allergy, 77(6), 1917-1920. Scopus4 WoS3 Europe PMC2 |
| 2022 | Mahnaz, R., Harrison, B., Hon, K., Gohar, S., Hadi, R., Aaron, F. K., . . . Sarah, V. (2022). Characterization of human nasal organoids from chronic rhinosinusitis patients.. Biology open, 11(8), 1-8. Scopus3 WoS3 Europe PMC3 |
| 2022 | Shaghayegh, G., Cooksley, C., Ramezanpour, M., Wormald, P. -J., Psaltis, A. J., & Vreugde, S. (2022). Chronic Rhinosinusitis, S. aureus Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines, 10(6), 1-28. Scopus33 WoS27 Europe PMC21 |
| 2021 | Suzuki, M., Cooksley, C., Suzuki, T., Ramezanpour, M., Nakazono, A., Nakamaru, Y., . . . Vreugde, S. (2021). TLR Signals in Epithelial Cells in the Nasal Cavity and Paranasal Sinuses. Frontiers in Allergy, 2, 780425-1-780425-11. Scopus15 WoS13 Europe PMC13 |
| 2021 | Kao, S., Bassiouni, A., Ramezanpour, M., Finnie, J., Chegeni, N., Colella, A. D., . . . Psaltis, A. J. (2021). Proteomic analysis of nasal mucus samples of healthy and chronic rhinosinusitis patients. Journal of Allergy and Clinical Immunology, 147(1), 168-178. Scopus42 WoS32 Europe PMC34 |
| 2021 | Suzuki, M., Ramezanpour, M., Cooksley, C., Ogi, K., Psaltis, A. J., Nakamaru, Y., . . . Vreugde, S. (2021). Metallothionein-3 is a clinical biomarker for tissue zinc levels in nasal mucosa. Auris Nasus Larynx, 48(5), 890-897. Scopus4 WoS4 Europe PMC4 |
| 2021 | Rastin, H., Ramezanpour, M., Hassan, K., Mazinani, A., Tung, T. T., Vreugde, S., & Losic, D. (2021). 3D bioprinting of a cell-laden antibacterial polysaccharide hydrogel composite. Carbohydrate Polymers, 264, 117989-1-117989-12. Scopus76 WoS62 Europe PMC37 |
| 2021 | Nakazono, A., Nakamaru, Y., Ramezanpour, M., Kondo, T., Watanabe, M., Hatakeyama, S., . . . Homma, A. (2021). Fluticasone Propionate Suppresses Poly(I:C)-Induced ACE2 in Primary Human Nasal Epithelial Cells. Frontiers in Cellular and Infection Microbiology, 11, 1-10. Scopus14 WoS12 Europe PMC11 |
| 2021 | Tuli, J. F., Ramezanpour, M., Cooksley, C., Psaltis, A. J., Wormald, P. -J., & Vreugde, S. (2021). Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.. Allergy, 76(11), 3459-3469. Scopus30 WoS27 Europe PMC24 |
| 2021 | Ramezanpour, M., Bolt, H., Hon, K., Bouras, G. S., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2021). Cytokine-induced modulation of sars-cov2 receptor expression in primary human nasal epithelial cells. Pathogens, 10(7), 18 pages. Scopus3 WoS3 Europe PMC2 |
| 2021 | Ramezanpour, M., Ogi, K., Liu, S., Tuli, J. F., Bennett, C., Masanobu, S., . . . Vreugde, S. (2021). Der p 1 disrupts the epithelial barrier and induces IL-6 production in patients with house dust mite allergic rhinitis. Frontiers in Allergy, 2, 692049-1-692049-9. Scopus17 WoS15 Europe PMC13 |
| 2021 | Rastin, H., Mansouri, N., Tung, T. T., Hassan, K., Mazinani, A., Ramezanpour, M., . . . Losic, D. (2021). Converging 2D nanomaterials and 3D bioprinting technology: state-of-the-art, challenges, and potential outlook in biomedical applications. Advanced Healthcare Materials, 10(22), e2101439-1-e2101439-50. Scopus29 WoS28 Europe PMC10 |
| 2021 | Ogi, K., Liu, S., Ramezanpour, M., Cooksley, C., Javadiyan, S., Fujieda, S., . . . Psaltis, A. J. (2021). Trimellitic anhydride facilitates transepithelial permeability disrupting tight junctions in sinonasal epithelial cells. Toxicology Letters, 353, 27-33. Scopus4 WoS4 Europe PMC4 |
| 2020 | Dong, D., Thomas, N., Ramezanpour, M., Alkis, P., Huang, S., Zhao, Y., . . . Vreudge, S. (2020). Inhibition of Staphylococcus aureus and Pseudomonas aeruginosa biofilms by quatsomes in low concentrations. Experimental Biology and Medicine, 245(1), 34-41. Scopus17 WoS18 Europe PMC12 |
| 2020 | Paramasivan, S., Bassiouni, A., Shiffer, A., Dillon, M. R., Cope, E. K., Cooksley, C., . . . Psaltis, A. J. (2020). The international sinonasal microbiome study (ISMS): a multi-centre, multi-national characterization of sinonasal bacterial ecology. Allergy, 75(8), 2033-2045. Scopus72 WoS68 Europe PMC62 |
| 2020 | Gouzos, M., Ramezanpour, M., Bassiouni, A., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2020). Antibiotics affect ROS production and fibroblast migration in an in-vitro model of sinonasal wound healing. Frontiers in Cellular and Infection Microbiology, 10, 110-1-110-12. Scopus23 WoS19 Europe PMC16 |
| 2020 | Bassiouni, A., Paramasivan, S., Shiffer, A., Dillon, M. R., Cope, E. K., Cooksley, C., . . . Psaltis, A. J. (2020). Microbiotyping the Sinonasal Microbiome.. Frontiers in Cellular and Infection Microbiology, 10, 137. Scopus33 WoS27 Europe PMC27 |
| 2020 | Goggin, R., Bennett, C., Ramezanpour, M., Hu, H., Fenix, K., Bassiouni, A., . . . Vreugde, S. (2020). Association between viral infection and increased mucosal eosinophils and CD8<sup>+</sup>CD103<sup>+</sup> T cells in chronic rhinosinusitis. International Forum of Allergy and Rhinology, 10(8), 978-980. Scopus1 |
| 2020 | Ramezanpour, M., Smith, J. P., Pstaltis, A. J., Wormald, P. J., & Vreugde, S. (2020). In vitro safety evaluation of a povidone‐iodine solution applied to human nasal epithelial cells. International Forum of Allergy and Rhinology, 10(10), 1141-1148. Scopus33 WoS30 Europe PMC25 |
| 2020 | Ramezanpour, M., Kao, S., Bassiouni, A., Chegeni, N., Colella, A., Chataway, K., . . . Psaltis, A. (2020). Scoping review of chronic rhinosinusitis proteomicsc rhinosinusitis proteomics. Rhinology, 58(5), 418-470. |
| 2020 | Panchatcharam, B. S., Cooksley, C. M., Ramezanpour, M., Vediappan, R. S., Bassiouni, A., Wormald, P. J., . . . Vreugde, S. (2020). Staphylococcus aureus biofilm exoproteins are cytotoxic to human nasal epithelial barrier in Chronic Rhinosinusitis. International Forum of Allergy and Rhinology, 10(7), 871-883. Scopus29 WoS22 Europe PMC18 |
| 2020 | Kao, S. S. -T., Bassiouni, A., Ramezanpour, M., Chegeni, N., Colella, A. D., Chataway, T. K., . . . Psaltis, A. J. (2020). Scoping review of chronic rhinosinusitis proteomics.. Rhinology, 58(5), 418-470. Scopus18 WoS15 Europe PMC12 |
| 2020 | Ramezanpour, M., Hu, H., Lau, A., Liu, S., De Silva, A., Bolt, H., . . . Vreugde, S. (2020). Increased serum IgG4 associates with asthma and tissue eosinophilia in chronic rhinosinusitis patients. Pathogens, 9(10), 1-6. Scopus4 WoS4 Europe PMC3 |
| 2020 | Suzuki, M., Ramezanpour, M., Cooksley, C., Lee, T. J., Jeong, B., Kao, S., . . . Vreugde, S. (2020). Zinc-depletion associates with tissue eosinophilia and collagen depletion in chronic rhinosinusitis. Rhinology, 58(5), 451-459. Scopus17 WoS15 Europe PMC15 |
| 2020 | Kao, S. S. T., Ramezanpour, M., Bassiouni, A., Finnie, J., Wormald, P. J., Vreugde, S., & Psaltis, A. J. (2020). Barrier disruptive effects of mucus isolated from chronic rhinosinusitis patients. Allergy, 75(1), 200-203. Scopus12 WoS13 Europe PMC9 |
| 2019 | Kao, S. S. T., Ramezanpour, M., Bassiouni, A., Wormald, P. J., Psaltis, A. J., & Vreugde, S. (2019). The effect of neutrophil serine proteases on human nasal epithelial cell barrier function. International Forum of Allergy and Rhinology, 9(10), 7 pages. Scopus34 WoS32 Europe PMC27 |
| 2019 | Hu, H., Ramezanpour, M., Hayes, A. J., Liu, S., Psaltis, A. J., Wormald, P., & Vreugde, S. (2019). Sub-Inhibitory Clindamycin and Azithromycin reduce S. aureus Exoprotein Induced Toxicity, Inflammation, Barrier Disruption and Invasion.. Journal of clinical medicine, 8(10), 16 pages. Scopus19 WoS18 Europe PMC15 |
| 2019 | Murphy, J., Ramezanpour, M., Drilling, A., Roscioli, E., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2019). In vitro characteristics of an airway barrier-disrupting factor secreted by Staphylococcus aureus. International Forum of Allergy and Rhinology, 9(2), 187-196. Scopus14 WoS13 Europe PMC11 |
| 2019 | Ramezanpour, M., Bolt, H., Psaltis, A., Wormald, P. J., & Vreugde, S. (2019). Inducing a Mucosal Barrier–Sparing Inflammatory Response in Laboratory-Grown Primary Human Nasal Epithelial Cells. Current Protocols in Toxicology, 80(1), e69. Scopus17 Europe PMC13 |
| 2019 | Cherian, L. M., Cooksley, C., Richter, K., Ramezanpour, M., Paramasivan, S., Wormald, P. J., . . . Psaltis, A. J. (2019). Effect of commercial nasal steroid preparation on bacterial growth. International Forum of Allergy and Rhinology, 9(7), 766-775. Scopus11 WoS11 Europe PMC7 |
| 2019 | Paramasivan, S., Bassiouni, A., Shiffer, A., Dillon, M., Cope, E., Cooksley, C., . . . Psaltis, A. (2019). The international sinonasal microbiome study (ISMS): a multi-centre, multi-national collaboration characterising the microbial ecology of the sinonasal cavity. Europe PMC1 |
| 2019 | Ramezanpour, M., Smith, J. L. P., Ooi, M. L., Gouzos, M., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2019). Deferiprone has anti-inflammatory properties and reduces fibroblast migration in vitro. Scientific Reports, 9(1), 9 pages. Scopus25 WoS23 Europe PMC21 |
| 2019 | Li, J., Ramezanpour, M., Fong, S. A., Cooksley, C., Murphy, J., Suzuki, M., . . . Vreugde, S. (2019). Pseudomonas aeruginosa exoprotein-induced barrier disruption correlates with elastase activity and marks Chronic Rhinosinusitis severity. Frontiers in Cellular and Infection Microbiology, 9, 9 pages. Scopus34 WoS29 Europe PMC27 |
| 2019 | Bennett, C., Ramezanpour, M., Cooksley, C., Vreugde, S., & Psaltis, A. J. (2019). Kappa-carrageenan sinus rinses reduce inflammation and intracellular Staphylococcus aureus infection in airway epithelial cells. International Forum of Allergy and Rhinology, 9(8), 918-925. Scopus12 WoS11 Europe PMC7 |
| 2018 | Murphy, J., Ramezanpour, M., Stach, N., Dubin, G., Psaltis, A., Wormald, P., & Vreugde, S. (2018). Staphylococcus Aureus V8 protease disrupts the integrity of the airway epithelial barrier and impairs IL-6 production in vitro. Laryngoscope, 128(1), 8-15. Scopus47 WoS39 Europe PMC37 |
| 2018 | Suzuki, M., Ramezanpour, M., Cooksley, C., Li, J., Nakamaru, Y., Homma, A., . . . Vreugde, S. (2018). Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells. American journal of respiratory cell and molecular biology, 59(4), 500-510. Scopus16 WoS16 Europe PMC14 |
| 2018 | Murphy, J., Ramezanpour, M., Roscioli, E., Psaltis, A. J., Wormald, P. J., & Vreugde, S. (2018). Mucosal zinc deficiency in chronic rhinosinusitis with nasal polyposis contributes to barrier disruption and decreases ZO-1. Allergy European Journal of Allergy and Clinical Immunology, 73(10), 2095-2097. Scopus27 WoS26 Europe PMC22 |
| 2018 | Ramezanpour, M., Bolt, H., Psaltis, A., Wormald, P., & Vreugde, S. (2018). Primary human nasal epithelial cells: a source of poly (I:C) LMW-induced IL-6 production. Scientific Reports, 8(1), 8 pages. Scopus26 WoS24 Europe PMC25 |
| 2017 | Ramezanpour, M., Murphy, J., Smith, J., Vreugde, S., & Psaltis, A. (2017). In vitro safety evaluation of human nasal epithelial cell monolayers exposed to carrageenan sinus wash. International Forum of Allergy and Rhinology, 7(12), 1170-1177. Scopus24 WoS20 Europe PMC15 |
| 2017 | Oue, S., Ramezanpour, M., Paramasivan, S., Miljkovic, D., Cooksley, C. M., Bassiouni, A., . . . Vreugde, S. (2017). Increased IL-13 expression is independently associated with neo-osteogenesis in patients with chronic rhinosinusitis. Journal of Allergy and Clinical Immunology, 140(5), 1444-1448.e11. Scopus12 WoS12 Europe PMC8 |
| 2017 | Richter, K., Facal, P., Thomas, N., Vandecandelaere, I., Ramezanpour, M., Cooksley, C., . . . Vreugde, S. (2017). Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections. ACS Applied Materials and Interfaces, 9(26), 21631-21638. Scopus49 WoS45 Europe PMC32 |
| 2017 | Ramezanpour, M., Rayan, A., Smith, J., & Vreugde, S. (2017). The effect of topical treatments for CRS on the sinonasal epithelial barrier. Rhinology, 55(2), 161-169. Scopus14 WoS13 Europe PMC11 |
| 2016 | Richter, K., Ramezanpour, M., Thomas, N., Prestidge, C. A., Wormald, P. J., & Vreugde, S. (2016). Mind “De GaPP”: in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms. International Forum of Allergy and Rhinology, 6(7), 737-743. Scopus45 WoS41 Europe PMC37 |
| 2016 | Ramezanpour, M., Moraitis, S., Smith, J., Wormald, P., & Vreugde, S. (2016). Th17 cytokines disrupt the airway mucosal barrier in chronic rhinosinusitis. Mediators of Inflammation, 2016, 9798206-1-9798206-7. Scopus72 WoS68 Europe PMC57 |
| 2015 | Thomas, N., Dong, D., Richter, K., Ramezanpour, M., Vreugde, S., Thierry, B., . . . Prestidge, C. (2015). Quatsomes for the treatment of Staphylococcus aureus biofilm. Journal of Materials Chemistry B, 3(14), 2770-2777. Scopus30 WoS28 Europe PMC17 |
| 2014 | Ramezanpour, M., da Silva, K. B., & Sanderson, B. J. (2014). The effect of sea anemone (H. magnifica) venom on two human breast cancer lines: death by apoptosis. Cytotechnology, 66(5), 845-852. Scopus25 WoS16 Europe PMC11 |
| 2014 | Ramezanpour, M., da Silva, K. B., & Sanderson, B. J. (2014). Venom present in sea anemone (Heteractis magnifica) induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria-mediated pathway. Biotechnology Letters, 36(3), 489-495. Scopus19 WoS17 Europe PMC9 |
| 2012 | Ramezanpour, M., Burke da Silva, K., & Sanderson, B. J. (2012). Differential susceptibilities of human lung, breast and skin cancer cell lines to killing by five sea anemone venoms. Journal of Venomous Animals and Toxins including Tropical Diseases, 18(2), 157-163. Scopus20 WoS16 |
| - | Marine bioactive products as anti-cancer agents: effects of sea anemone venom on breast and lung cancer cells (2014). Cancer Cell & Microenvironment. |
| Year | Citation |
|---|---|
| 2016 | Sanderson, B., Burke Da Silva, K., & Ramezanpour, M. (2016). How Venom from the Magnificent Sea Anemone, Heteractis magnifica, Kills Breast and Lung Cancer Cells. In S. Goffredo, & Z. Dubinsky (Eds.), The Cnidaria, Past, Present and Future The world of Medusa and her sisters (pp. 669-682). Switzerland: Springer. DOI Scopus1 |
| Date | Project/ No. | Investigators | Funding Body | Amount |
|---|---|---|---|---|
| 2020 | A personalised therapeutic plan for S. aureus recalcitrant CRS |
Professor Alkis Psaltis Dr Mahnaz Ramezanpour |
The Garnett Passe and Rodney Williams Memorial Foundation | $362,363 |
- Demonstrator: Flinders University, 2011-2014
Undergraduate demonstrating of first-year flinders biological topic
- Tutor: Flinders University, 2012-2014
Tutoring undergraduate students in the medical biochemistry department
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2024 | Principal Supervisor | Bacteriophage therapy in CRS patient nasal wound healing | Doctor of Philosophy | Doctorate | Full Time | Mr Jordan Hall |
| 2023 | Co-Supervisor | Potential use of essential oils from ethno-medicinal plants in clinical research | Doctor of Philosophy | Doctorate | Full Time | Miss Sumeena Karki |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2021 - 2023 | Co-Supervisor | Investigating Transcription Factors in the Human Airway Mucosal Immunoepigenetics of Chronic Inflammatory Disease | Master of Philosophy (Surgery) | Master | Full Time | Mr Harrison Burchill Bolt |
| 2019 - 2022 | Co-Supervisor | Effects of Pseudomonas aeruginosa exoproteins on nasal mucosal barrier in chronic rhinosinusitis | Doctor of Philosophy | Doctorate | Full Time | Mrs Jannatul Ferdoush Tuli |
| 2018 - 2020 | Co-Supervisor | Nasal mucus: friend or foe? The effect of mucus on mucosal barrier dysfunction in chronic rhinosinusitis | Doctor of Philosophy | Doctorate | Full Time | Dr Stephen Shih-Teng Kao |
| Date | Role | Research Topic | Location | Program | Supervision Type | Student Load | Student Name |
|---|---|---|---|---|---|---|---|
| 2023 - 2024 | Principal Supervisor | Influenza-A infection liberates bacteria from biofilms in Chronic rhinosinusitis leading to an increased inflammatory response | University of Adelaide | - | Honours | Full Time | Jordan Hall |
| 2022 - 2023 | Principal Supervisor | Interleukin-33 Expression and Impact in Chronic Rhinosinusitis Airway Epithelial Cells in Response to Viral Infection | University of Adelaide | - | Honours | Full Time | Dray Harrison |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2020 - ongoing | Member | BHI Management Committee meeting | Basi Hetzel Institute | Australia |
| 2018 - 2018 | Member | Women’s and Children’s Hospital (WCH) Foundation Research Grants Committee | Women’s and Children’s Hospital (WCH) | Australia |
| 2018 - ongoing | Member | Woodcutters Road Environmental Protection Association | Woodcutters Road Environmental Protection Association | Australia |
| 2015 - ongoing | Member | Astronomical Society of Flinders University | Astronomical Society of Flinders University | Australia |
